This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo
United Kingdom - English

United Kingdom - English

United Kingdom | English

These country specific websites are specifically intended for healthcare professionals in listed countries only.

Europe

Deutschland - DeutschDeutschland - Deutsch España - EspañolEspaña - Español Italia - ItalianoItalia - Italiano United Kingdom - EnglishUnited Kingdom - English

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

Bone Health

STEXEROL-D3 Colecalciferol

Stexerol-D3 is indicated in adults, the elderly and adolescents for prevention and treatment of vitamin D deficiency, or as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.1

 

  • INTRODUCTION

    Stexerol-D3 is a licensed treatment for the prevention and treatment of vitamin D deficiency. Find out how Stexerol-D3 can meet the needs of your patients.

  • DIAGNOSIS

    Information on confirming a diagnosis of vitamin D deficiency.

  • PRESCRIBING STEXEROL-D3

    Click here for guidance on how to prescribe Stexerol-D3, including information on dosing and administration.

  • RESOURCES

    Access tools and resources to assist with the management of vitamin D deficiency.

  • PRESCRIBING INFORMATION

    Direction on prescribing Stexerol-D3 covering information on licensed indication, dose, side effects, special precautions and contraindications. This section also contains information on how to report a side effect.

Average:

  • References

    1. Stexerol-D3 Tablets SPC

    KKI/UK/GEN/0134 November 2023